Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autoinoculation versus intralesional bleomycin for multiple recalcitrant warts
PACTR201803003151322Completed
- Sponsor
- Zagazig University Faculty of Medicine
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bleomycin in human papillomavirus infection, verruca and anogenital warts (2 arms), sponsored by Zagazig University Faculty of Medicine. Started Feb 2017; status: completed.
02
Drugs
bleomycin
03
Conditions
human papillomavirus infectionverrucaanogenital warts
Beyond the preview
Go deeper on PACTR201803003151322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201803003151322.